United Kingdom

People: Align Technology Inc (ALGN.OQ)

ALGN.OQ on NASDAQ Stock Exchange Global Select Market

16 Sep 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Larkin, Charles 

Mr. Charles Raymond Larkin (Ray) Jr. is Independent Chairman of the Board of the Company. Mr. Larkin has served as a director of Align since March 2004. In February 2006, Mr. Larkin was appointed as Chairman of the Board. Until 2018, he was a Principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. From 2001 to 2007, he served as a part time Venture Partner at Cutlass Capital, a venture capital firm. Mr. Larkin was previously Chairman and Chief Executive Officer at Eunoe, Inc., a medical device company. From 1983 to March 1998, he held various executive positions with Nellcor Puritan Bennett, Inc., a medical instrumentation company, for which he served as President and Chief Executive Officer from 1989 until 1998. Mr. Larkin also held various positions of increasing responsibility at Bentley Laboratories/American Hospital Supply from 1976 to 1983. He currently serves on the board of directors of REVA Medical Inc., a medical device company developing and commercializing bioresorbable stents for the treatment of coronary artery disease. He also served on the board of directors of Heartware, Inc. prior to its acquisition by Medtronic, plc in 2016. Mr. Larkin received his B.S. in Industrial Management from LaSalle University.

Basic Compensation

Total Annual Compensation, USD 136,667
Restricted Stock Award, USD 400,264
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 536,931

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Charles Larkin


Joseph Hogan


John Morici


Zelko Relic


Raj Pudipeddi


Simon Beard

As Of  31 Dec 2018